Literature DB >> 19183275

Mycoplasma pneumoniae J-domain protein required for terminal organelle function.

Jason M Cloward1, Duncan C Krause.   

Abstract

The cell wall-less prokaryote Mycoplasma pneumoniae causes tracheobronchitis and primary atypical pneumonia in humans. Colonization of the respiratory epithelium requires proper assembly of a complex, multifunctional, polar terminal organelle. Loss of a predicted J-domain protein also having domains unique to mycoplasma terminal organelle proteins (TopJ) resulted in a non-motile, adherence-deficient phenotype. J-domain proteins typically stimulate ATPase activity of Hsp70 chaperones to bind nascent peptides for proper folding, translocation or macromolecular assembly, or to resolve stress-induced protein aggregates. By Western immunoblotting all defined terminal organelle proteins examined except protein P24 remained at wild-type levels in the topJ mutant; previous studies established that P24 is required for normal initiation of terminal organelle formation. Nevertheless, terminal organelle proteins P1, P30, HMW1 and P41 failed to localize to a cell pole, and when evaluated quantitatively, P30 and HMW1 foci were undetectable in >40% of cells. Complementation of the topJ mutant with the recombinant wild-type topJ allele largely restored terminal organelle development, gliding motility and cytadherence. We propose that this J-domain protein, which localizes to the base of the terminal organelle in wild-type M. pneumoniae, functions in the late stages of assembly, positioning, or both, of nascent terminal organelles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183275      PMCID: PMC5833977          DOI: 10.1111/j.1365-2958.2009.06602.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  64 in total

1.  Defining the mycoplasma 'cytoskeleton': the protein composition of the Triton X-100 insoluble fraction of the bacterium Mycoplasma pneumoniae determined by 2-D gel electrophoresis and mass spectrometry.

Authors:  J T Regula; G Boguth; A Görg; J Hegermann; F Mayer; R Frank; R Herrmann
Journal:  Microbiology       Date:  2001-04       Impact factor: 2.777

Review 2.  Folding of newly translated proteins in vivo: the role of molecular chaperones.

Authors:  J Frydman
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

3.  Terminal organelle development in the cell wall-less bacterium Mycoplasma pneumoniae.

Authors:  Benjamin M Hasselbring; Jarrat L Jordan; Robert W Krause; Duncan C Krause
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-24       Impact factor: 11.205

4.  Mycoplasma genitalium mg200 and mg386 genes are involved in gliding motility but not in cytadherence.

Authors:  Oscar Q Pich; Raul Burgos; Mario Ferrer-Navarro; Enrique Querol; Jaume Piñol
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

5.  Expression in Mycoplasma pneumoniae of the recombinant gene encoding the cytadherence-associated protein HMW1 and identification of HMW4 as a product.

Authors:  T W Hahn; K A Krebes; D C Krause
Journal:  Mol Microbiol       Date:  1996-03       Impact factor: 3.501

6.  Motility and multiplication of Mycoplasma pneumoniae. A phase contrast study.

Authors:  W Bredt
Journal:  Pathol Microbiol (Basel)       Date:  1968

7.  Mycoplasma pneumoniae in hamster tracheal organ culture: immunofluorescent and electron microscopic studies.

Authors:  A M Collier; W A Clyde; F W Denny
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

8.  Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma.

Authors:  J G Tully; R F Whitcomb; H F Clark; D L Williamson
Journal:  Science       Date:  1977-03-04       Impact factor: 47.728

9.  Localization and biochemical characterization of the ORF6 gene product of the Mycoplasma pneumoniae P1 operon.

Authors:  G Layh-Schmitt; R Herrmann
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

10.  New laboratory techniques for isolation of Mycoplasma pneumoniae.

Authors:  J G Tully
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec
View more
  16 in total

1.  Loss of co-chaperone TopJ impacts adhesin P1 presentation and terminal organelle maturation in Mycoplasma pneumoniae.

Authors:  Jason M Cloward; Duncan C Krause
Journal:  Mol Microbiol       Date:  2011-06-23       Impact factor: 3.501

2.  P65 truncation impacts P30 dynamics during Mycoplasma pneumoniae gliding.

Authors:  Benjamin M Hasselbring; Edward S Sheppard; Duncan C Krause
Journal:  J Bacteriol       Date:  2012-04-27       Impact factor: 3.490

3.  Domain analysis of protein P30 in Mycoplasma pneumoniae cytadherence and gliding motility.

Authors:  How-Yi Chang; Jarrat L Jordan; Duncan C Krause
Journal:  J Bacteriol       Date:  2011-01-21       Impact factor: 3.490

Review 4.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

5.  Protein kinase/phosphatase function correlates with gliding motility in Mycoplasma pneumoniae.

Authors:  Clinton A Page; Duncan C Krause
Journal:  J Bacteriol       Date:  2013-02-08       Impact factor: 3.490

6.  Functional domain analysis of the Mycoplasma pneumoniae co-chaperone TopJ.

Authors:  Jason M Cloward; Duncan C Krause
Journal:  Mol Microbiol       Date:  2010-05-12       Impact factor: 3.501

Review 7.  Mycoplasma pneumoniae, an underutilized model for bacterial cell biology.

Authors:  Mitchell F Balish
Journal:  J Bacteriol       Date:  2014-08-25       Impact factor: 3.490

8.  A major determinant for gliding motility in Mycoplasma genitalium: the interaction between the terminal organelle proteins MG200 and MG491.

Authors:  Luca Martinelli; Daniela Lalli; Luis García-Morales; Mercè Ratera; Enrique Querol; Jaume Piñol; Ignacio Fita; Bárbara M Calisto
Journal:  J Biol Chem       Date:  2014-12-03       Impact factor: 5.157

9.  Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain.

Authors:  S M Szczepanek; S Majumder; E S Sheppard; X Liao; D Rood; E R Tulman; S Wyand; D C Krause; L K Silbart; S J Geary
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

10.  Distinct Mycoplasma pneumoniae Interactions with Sulfated and Sialylated Receptors.

Authors:  Caitlin R Williams; Li Chen; Edward S Sheppard; Pradeep Chopra; Jason Locklin; Geert-Jan Boons; Duncan C Krause
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.